-
Non-injectable Insulin Market Size to Exceed USD 2.23 Billion by 2030, with a CAGR of 8.6%, according to Persistence Market Research
23 Jan 2024 12:38 GMT
… the market: Afrezza and Exubera. However, Exubera was discontinued due to poor … emphasizing the need for diverse insulin delivery methods. Moreover, technological … alternative and witnessing advancements in drug delivery technology. Distribution Channels …
-
Mark Bennett: Museum of Failure's silly, strange, tragic flops includes Terre Haute-made Exubera
30 Jun 2023 03:03 GMT
… expectations. Industry publications predicted Exubera would yield Pfizer $1.5 billion in … change in the delivery of insulin,” West said. “But according to … of blister packs into the inhaler,” West said.
Healthcare providers were …
-
China to launch world’s first oral insulin for Type-2 diabetes: Report
26 May 2023 13:00 GMT
… from the traditional injectable insulin market. Therefore, there … forms of insulin. Hence, oral insulin will always … 2006, Pfizer launched the world’s first inhaled insulin, Exubera, but … barely a year later, it withdrew Exubera …
-
China poised to deliver world’s first oral insulin for Type 2 diabetes: GlobalData
26 May 2023 09:09 GMT
… said, “Even though insulin delivery through injections has … forms of insulin. Hence, oral insulin will always … 2006, Pfizer launched the world’s first inhaled insulin, Exubera, but … barely a year later, it withdrew Exubera …
-
The Application of the Insulin to C-Peptide Molar Ratio (ICPR) in Primary Screening for Insulin Antibodies in Type 2 Diabetes Mellitus Patients: A Further Quantitative Study on the Relationship Between ICPR and Insulin Antibodies
22 Apr 2023 07:40 GMT
… furosemide; (10) recent application of drugs affecting uric acid metabolisms such … the effects of insulin therapy and glucose-lowering drugs on blood glucose … efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive …
-
Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market is projected to reach US$56,737.2 Million in 2031: Visiongain Reports Ltd
27 Sep 2022 09:45 GMT
… diseases and encouraging drug adherence. Prefilled … Pfizer's Exubera (inhalable insulin) and Medtronic's Veo insulin pump (inhalable insulin). Insulin … injections are a substantial market for injectable drug …
-
Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market is projected to reach US$56,737.2 Million in 2031: Visiongain Reports Ltd
16 Sep 2022 09:30 GMT
… diseases and encouraging drug adherence. Prefilled … Pfizer's Exubera (inhalable insulin) and Medtronic's Veo insulin pump (inhalable insulin). Insulin … injections are a substantial market for injectable drug …
-
Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market is projected to reach US$56,737.2 Million in 2031: Visiongain Reports Ltd
24 Jun 2022 15:57 GMT
… diseases and encouraging drug adherence. Prefilled … Pfizer's Exubera (inhalable insulin) and Medtronic's Veo insulin pump (inhalable insulin). Insulin … injections are a substantial market for injectable drug …
-
Is non─injectable insulin the future of diabetes management?
14 Jan 2022 14:07 GMT
… between specific genetic variants and drug response returned small and inconsistent … in improvement in insulin secretion and sensitivity to drug therapy
The main … US FDA-approved powdered inhaled native human insulin (Exubera, Pfizer) was withdrawn from the …
-
Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market is projected to reach US$56,737.2 Million in 2031: Visiongain Research Inc
13 Dec 2021 14:30 GMT
… diseases and encouraging drug adherence. Prefilled … Pfizer's Exubera (inhalable insulin) and Medtronic's Veo insulin pump (inhalable insulin). Insulin … injections are a substantial market for injectable drug …